
Conference Coverage
Latest Content

The Famine’s Lessons: How Disease Stayed With Irish Americans for Generations—and Why It Still Matters

Is Climate Change Quietly Fueling a Global Physical Inactivity Crisis?

Low Risk of Severe COVID-19 in Vaccinated Patients With MS

FDA Expands Secukinumab Approval to Patients 12 Years and Older With Hidradenitis Suppurativa

Lebrikizumab Pediatric Data Could Expand AD Treatment Access

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

Long-Term Safety of Vutrisiran Confirmed in ATTR Amyloidosis Analysis
Vutrisiran kept a favorable safety profile in patients with transthyretin amyloidosis treated for up to 58 months, with AE rates comparable to placebo and no new safety concerns.

Legislation that passed the Senate will introduce reform in how pharmacy benefit managers are addressed by CMS starting in 2028.

Dr Wilfong's commentary will appear in the April issue of Evidence-Based Oncology.

Galleri trial data show liquid biopsy multicancer early detection tests may cut stage IV diagnoses, despite the missed primary end point.

Reproductive health conditions raise child desire but lower pregnancy intentions, spotlighting infertility gaps in women’s health and urging proactive counseling and coverage reform.

The website officially launched on February 5, introducing a key part of the Trump administration’s health care plan.

New studies link abortion bans to higher births and WIC demand and spotlight care-access gaps, cancer disparities, and value-based reforms shaping 2026.

The mental health burden of vitiligo closely resembles atopic dermatitis but differs significantly from psoriasis, a study suggests.

GPT-4o reliably scored alopecia areata severity from scalp images, showing strong concordance with experienced dermatology providers without prior AI training.

Deupirfenidone received orphan drug designation from the FDA and European Commission for idiopathic pulmonary fibrosis treatment.










































































